DrugCite
Search

ZEMPLAR

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Zemplar Adverse Events Reported to the FDA Over Time

How are Zemplar adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Zemplar, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Zemplar is flagged as the suspect drug causing the adverse event.

Most Common Zemplar Adverse Events Reported to the FDA

What are the most common Zemplar adverse events reported to the FDA?

Dyspnoea
194 (1.97%)
Death
161 (1.64%)
Cardiac Failure
137 (1.39%)
Pyrexia
125 (1.27%)
Nausea
122 (1.24%)
Myocardial Infarction
118 (1.2%)
Fatigue
116 (1.18%)
Cardiac Arrest
112 (1.14%)
Diarrhoea
112 (1.14%)
Fall
108 (1.1%)
Dizziness
103 (1.05%)
Show More Show More
Vomiting
93 (.95%)
Sepsis
88 (.89%)
Asthenia
87 (.88%)
Pneumonia
86 (.87%)
Hypertension
81 (.82%)
Renal Failure
75 (.76%)
Oedema Peripheral
73 (.74%)
Headache
71 (.72%)
Hypercalcaemia
69 (.7%)
General Physical Health Deteriorati...
65 (.66%)
Pain In Extremity
65 (.66%)
Chest Pain
62 (.63%)
Dysgeusia
62 (.63%)
Renal Failure Chronic
62 (.63%)
Acute Myocardial Infarction
61 (.62%)
Coronary Artery Disease
61 (.62%)
Blood Calcium Increased
60 (.61%)
Pruritus
58 (.59%)
Cerebrovascular Accident
52 (.53%)
Dry Mouth
52 (.53%)
Angina Pectoris
50 (.51%)
Atrial Fibrillation
49 (.5%)
Malaise
49 (.5%)
Cough
46 (.47%)
Anaemia
45 (.46%)
Arrhythmia
45 (.46%)
Arthralgia
45 (.46%)
Blood Parathyroid Hormone Increased
44 (.45%)
Cardiac Failure Congestive
44 (.45%)
Abdominal Pain
43 (.44%)
Peripheral Arterial Occlusive Disea...
43 (.44%)
Weight Decreased
43 (.44%)
Hyperphosphataemia
41 (.42%)
Hypotension
41 (.42%)
Pulmonary Oedema
40 (.41%)
Skin Ulcer
40 (.41%)
Urinary Tract Infection
39 (.4%)
Confusional State
38 (.39%)
Constipation
38 (.39%)
Rash
37 (.38%)
Back Pain
36 (.37%)
Cardiac Disorder
36 (.37%)
Infection
36 (.37%)
Gastrointestinal Haemorrhage
35 (.36%)
Staphylococcal Bacteraemia
35 (.36%)
Hypertensive Crisis
34 (.35%)
Myalgia
34 (.35%)
Staphylococcal Infection
34 (.35%)
Arteriovenous Fistula Site Complica...
33 (.34%)
Bone Pain
33 (.34%)
C-reactive Protein Increased
33 (.34%)
Hyperkalaemia
33 (.34%)
Respiratory Tract Infection
33 (.34%)
Muscle Spasms
31 (.32%)
Cerebral Haemorrhage
30 (.31%)
Pain
30 (.31%)
Abdominal Pain Upper
29 (.29%)
Gangrene
29 (.29%)
Pleural Effusion
29 (.29%)
Renal Transplant
29 (.29%)
Blood Creatinine Increased
28 (.28%)
Fluid Retention
28 (.28%)
Pericardial Effusion
28 (.28%)
Chills
27 (.27%)
Inflammation
27 (.27%)
Somnolence
27 (.27%)
Blood Pressure Decreased
26 (.26%)
Cardio-respiratory Arrest
26 (.26%)
Septic Shock
26 (.26%)
Acute Pulmonary Oedema
25 (.25%)
Anorexia
25 (.25%)
Chronic Obstructive Pulmonary Disea...
25 (.25%)
Feeling Abnormal
25 (.25%)
Hospitalisation
25 (.25%)
Shunt Occlusion
25 (.25%)
Blood Pressure Increased
24 (.24%)
Dehydration
24 (.24%)
Tachycardia
24 (.24%)
Arteriosclerosis
23 (.23%)
Staphylococcal Sepsis
23 (.23%)
Decreased Appetite
22 (.22%)
Loss Of Consciousness
22 (.22%)
Pulmonary Embolism
22 (.22%)
Syncope
22 (.22%)
White Blood Cell Count Increased
22 (.22%)
Gastroenteritis
21 (.21%)
Haemorrhage
21 (.21%)
Vertigo
21 (.21%)
Arteriovenous Shunt Operation
20 (.2%)
Convulsion
20 (.2%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Zemplar, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Zemplar is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Zemplar

What are the most common Zemplar adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Zemplar, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Zemplar is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Zemplar According to Those Reporting Adverse Events

Why are people taking Zemplar, according to those reporting adverse events to the FDA?

Hyperparathyroidism Secondary
1135
Hyperparathyroidism
695
Drug Use For Unknown Indication
434
Product Used For Unknown Indication
344
Renal Failure Chronic
269
Renal Failure
88
Show More Show More
Renal Disorder
65
Nephropathy
27
Secondary Hyperthyroidism
24
Dialysis
23
Hypoparathyroidism Secondary
20
Blood Parathyroid Hormone Increased
18
Renal Impairment
14
Renal Osteodystrophy
10
Haemodialysis
10
Blood Calcium Abnormal
10
Vitamin Supplementation
10
Vitamin D Deficiency
9
Hypoparathyroidism
8
Parathyroid Disorder
8
Prophylaxis
8
Vitamin D
7
Congenital Cystic Kidney Disease
5
Hyperphosphataemia
5
Anaemia
5
Secondary Hypertension
4
Diabetes Mellitus
4
Red Blood Cell Abnormality
4
Diabetic End Stage Renal Disease
4
Thyroid Disorder
4
Electrolyte Imbalance
4
Secondary Hypothyroidism
4
Hyperthyroidism
4
Blood Phosphorus Abnormal
4
Hypothyroidism
3
Proteinuria
3
Blood Phosphorus Increased
3
Mesangioproliferative Glomeruloneph...
3
Vitamin D Decreased
3
Osteoporosis Prophylaxis
2
Hyperparathyroidism Tertiary
2
Glomerulonephritis Chronic
2
Bone Disorder
2
Glomerulonephritis
2
Calcium Metabolism Disorder
2
Vitamin C
2
Unevaluable Event
2
Glomerulonephritis Proliferative
2
Blood Phosphorus
2
Nephrosclerosis
2
Renal Cyst
2

Drug Labels

LabelLabelerEffective
ZemplarAbbott Laboratories20-APR-11
ZemplarAbbott Laboratories06-AUG-12
ZemplarCardinal Health10-APR-13

Zemplar Case Reports

What Zemplar safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Zemplar. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Zemplar.